EYLEA 40MG SOL. FOR INTRAVITREAL INJ
سعر EYLEA 40MG SOL. FOR INTRAVITREAL INJ
8260.00 جنية
الشركة المنتجة لـ EYLEA 40MG SOL. FOR INTRAVITREAL INJ
BAYER BITTERFELD GMBH-GERMANY > BAYER HEALTHCARE
المادة الفعالة EYLEA 40MG SOL. FOR INTRAVITREAL INJ
AFLIBERCEPT
معلومات عن EYLEA 40MG SOL. FOR INTRAVITREAL INJ
Eylea is indicated for the treatment of:
Neovascular (Wet) Age-Related Macular Degeneration (AMD)
Macular Edema Following Retinal Vein Occlusion (RVO)
Diabetic Macular Edema (DME)
Diabetic Retinopathy (DR) in Patients with DME
